AUT-00063

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameAUT-00063
Drug Alias NameAUT-00063
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated potassium channel subunit Kv3.1 modulators
TargetsVoltage-gated potassium channel subunit Kv3.1
Therapy Area/IndicationsTinnitusPresbycusisHearing Loss
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAutifony Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAutifony Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsTinnitusPresbycusisHearing Loss

Other Information

ATC CodeN/A
Related LinksN/A